🇺🇸 Nitroglycerin I in United States

FDA authorised Nitroglycerin I on 30 September 1981

Marketing authorisations

FDA — authorised 30 September 1981

  • Application: NDA018537
  • Marketing authorisation holder: HOSPIRA
  • Local brand name: TRIDIL
  • Indication: INJECTABLE — INJECTION
  • Status: approved

Read official source →

FDA

  • Status: approved

Nitroglycerin I in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Nitroglycerin I approved in United States?

Yes. FDA authorised it on 30 September 1981; FDA has authorised it.

Who is the marketing authorisation holder for Nitroglycerin I in United States?

HOSPIRA holds the US marketing authorisation.